ScanSource (SCSC) Financials

$39.60 -0.62 (-1.54%)

As of 03:49 PM Eastern

Annual Income Statements for ScanSource

This table shows ScanSource's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022
Period end date	6/30/2024	6/30/2023	6/30/2022
Net Income / (Loss) Attributable to Common Shareholders	77	90	89
Consolidated Net Income / (Loss)	77	90	89
Net Income / (Loss) Continuing Operations	77	88	89
Total Pre-Tax Income	100	122	119
Total Operating Income	90	136	122
Total Gross Profit	399	449	427
Total Revenue	3,260	3,788	3,530
Operating Revenue	3,260	3,788	3,530
Total Cost of Revenue	2,861	3,338	3,103
Operating Cost of Revenue	2,861	3,338	3,103
Total Operating Expenses	309	313	304
Selling, General & Admin Expense	277	286	275
Depreciation Expense	11	11	11
Amortization Expense	16	17	18
Restructuring Charge	4.36	0.00	0.00
Total Other Income / (Expense), net	9.52	-14	-3.54
Interest Expense	13	20	6.52
Interest & Investment Income	9.38	7.41	4.33
Other Income / (Expense), net	13	-1.66	-1.35
Income Tax Expense	23	34	30
Net Income / (Loss) Discontinued Operations	0.00	1.72	0.10
Basic Earnings per Share	$3.10	$3.57	$3.48
Weighted Average Basic Shares Outstanding	24.87M	25.14M	25.50M
Diluted Earnings per Share	$3.06	$3.54	$3.45
Weighted Average Diluted Shares Outstanding	25.22M	25.36M	25.76M
Weighted Average Basic & Diluted Shares Outstanding	24.03M	24.84M	25.19M

This table shows ScanSource's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Income / (Loss) Attributable to Common Shareholders	17	17	17	16	13	33	15	19	21	26	24
Consolidated Net Income / (Loss)	17	17	17	16	13	33	15	19	21	26	24
Net Income / (Loss) Continuing Operations	17	17	17	16	13	33	15	17	21	26	24
Total Pre-Tax Income	24	20	23	23	18	40	19	23	30	36	32
Total Operating Income	22	18	18	22	18	27	24	27	34	39	35
Total Gross Profit	100	102	102	97	94	101	107	109	112	115	113
Total Revenue	705	747	776	746	753	885	876	947	886	1,011	944
Operating Revenue	705	747	776	746	753	885	876	947	886	1,011	944
Total Cost of Revenue	605	646	674	649	658	784	770	838	774	896	830
Operating Cost of Revenue	605	646	674	649	658	784	770	838	774	896	830
Total Operating Expenses	78	83	84	75	77	74	82	81	77	76	79
Selling, General & Admin Expense	70	74	72	68	67	67	75	74	71	69	72
Depreciation Expense	2.32	2.90	2.86	2.77	2.69	2.96	2.80	2.83	2.64	2.68	2.76
Amortization Expense	4.94	5.00	4.36	3.74	3.75	4.04	4.19	4.19	4.17	4.15	4.24
Restructuring Charge	0.00	0.31	5.07	-	3.92	0.00	0.00	-	0.00	-	-
Other Special Charges / (Income)	0.90	1.14	-	-	-	0.00	-	-	-	-	-
Total Other Income / (Expense), net	1.89	1.27	5.33	0.82	0.41	13	-4.94	-3.83	-4.37	-3.24	-2.61
Interest Expense	1.84	1.97	2.11	2.09	2.00	3.36	5.59	5.56	5.72	5.06	3.45
Interest & Investment Income	2.84	2.69	2.66	3.29	2.65	2.12	1.33	2.09	1.71	2.03	1.59
Other Income / (Expense), net	0.88	0.54	4.78	-0.38	-0.24	14	-0.68	-0.35	-0.36	-0.21	-0.75
Income Tax Expense	6.80	2.66	5.99	6.60	5.15	7.32	3.72	6.37	8.69	10	8.24
Basic Earnings per Share	$0.75	$0.72	$0.70	$0.66	$0.51	$1.31	$0.62	$0.76	$0.84	$1.02	$0.95
Weighted Average Basic Shares Outstanding	23.28M	23.81M	24.15M	24.87M	25.03M	25.04M	24.89M	25.14M	25.20M	25.29M	25.20M
Diluted Earnings per Share	$0.74	$0.70	$0.69	$0.66	$0.50	$1.29	$0.61	$0.76	$0.83	$1.01	$0.94
Weighted Average Diluted Shares Outstanding	23.60M	24.22M	24.65M	25.22M	25.44M	25.33M	25.18M	25.36M	25.44M	25.50M	25.45M
Weighted Average Basic & Diluted Shares Outstanding	22.60M	23.46M	0.00	24.03M	24.71M	25.17M	24.97M	24.84M	24.90M	25.35M	25.25M

This table details how cash moves in and out of ScanSource's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022
Period end date	6/30/2024	6/30/2023	6/30/2022
Net Change in Cash & Equivalents	149	-1.81	-25
Net Cash From Operating Activities	372	-36	-124
Net Cash From Continuing Operating Activities	372	-36	-124
Net Income / (Loss) Continuing Operations	77	88	89
Consolidated Net Income / (Loss)	77	90	89
Net Income / (Loss) Discontinued Operations	0.00	1.72	0.10
Depreciation Expense	28	29	30
Amortization Expense	0.39	0.58	0.42
Non-Cash Adjustments To Reconcile Net Income	3.80	14	13
Changes in Operating Assets and Liabilities, net	262	-167	-257
Net Cash From Discontinued Operating Activities	0.00	0.00	0.00
Net Cash From Investing Activities	9.05	-8.26	-3.72
Net Cash From Continuing Investing Activities	9.05	-8.26	-3.72
Purchase of Property, Plant & Equipment	-8.56	-9.98	-6.85
Divestitures	18	1.72	3.13
Net Cash From Discontinued Investing Activities	0.00	0.00	0.00
Net Cash From Financing Activities	-228	40	108
Net Cash From Continuing Financing Activities	-228	40	108
Repayment of Debt	-1,447	-2,442	-2,040
Repurchase of Common Equity	-43	-16	-18
Issuance of Debt	1,260	2,499	2,166
Other Financing Activities, net	1.94	-1.55	-0.45
Net Cash From Discontinued Financing Activities	0.00	0.00	0.00
Effect of Exchange Rate Changes	-3.64	2.69	-4.76
Cash Interest Paid	13	19	6.07
Cash Income Taxes Paid	27	29	29

This table details how cash moves in and out of ScanSource's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Change in Cash & Equivalents	36	-35	-40	26	114	2.34	6.47	-1.20	-29	26	2.49
Net Cash From Operating Activities	66	-6.19	45	55	160	63	94	-15	55	-27	-48
Net Cash From Continuing Operating Activities	66	-6.19	45	55	160	63	94	-15	55	-27	-48
Net Income / (Loss) Continuing Operations	17	17	17	16	13	33	15	17	21	26	24
Consolidated Net Income / (Loss)	17	17	17	16	13	33	15	19	21	26	24
Depreciation Expense	7.49	8.13	7.47	6.79	6.74	7.26	7.22	7.26	7.07	7.06	7.23
Amortization Expense	0.10	0.10	0.10	0.10	0.10	0.10	0.10	0.10	0.10	0.10	0.29
Non-Cash Adjustments To Reconcile Net Income	4.69	7.29	4.17	4.67	3.80	-12	6.94	3.53	4.78	3.29	2.44
Changes in Operating Assets and Liabilities, net	36	-39	16	27	137	35	64	-43	22	-63	-82
Net Cash From Investing Activities	-1.42	0.77	-59	-1.65	-2.42	15	-2.32	-1.71	-2.29	-3.58	-0.68
Net Cash From Continuing Investing Activities	-1.42	0.77	-59	-1.65	-2.42	15	-2.32	-1.71	-2.29	-3.58	-0.68
Purchase of Property, Plant & Equipment	-1.42	-1.97	-2.38	-1.27	-2.42	-2.55	-2.32	-3.43	-2.29	-3.58	-0.68
Net Cash From Financing Activities	-31	-26	-27	-24	-43	-78	-83	14	-82	55	53
Net Cash From Continuing Financing Activities	-31	-26	-27	-24	-43	-78	-83	14	-82	55	53
Repayment of Debt	-14	-22	-9.06	-19	-131	-626	-671	-608	-712	-597	-525
Repurchase of Common Equity	-29	-24	-28	-22	-20	-1.25	0.00	-4.93	-11	-	-
Issuance of Debt	12	18	8.38	17	108	546	589	627	640	653	579
Other Financing Activities, net	0.00	2.51	2.18	0.11	0.18	3.16	-1.51	0.03	0.12	-1.11	-0.59
Effect of Exchange Rate Changes	2.19	-3.38	0.61	-2.86	-1.03	1.50	-1.26	1.81	0.84	1.38	-1.34

This table presents ScanSource's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022
Period end date	6/30/2024	6/30/2023	6/30/2022
Total Assets	1,779	2,068	1,937
Total Current Assets	1,405	1,657	1,524
Cash & Equivalents	185	36	38
Accounts Receivable	582	753	729
Inventories, net	513	758	615
Prepaid Expenses	125	110	142
Plant, Property, & Equipment, net	34	0.00	0.00
Total Noncurrent Assets	341	411	414
Goodwill	206	217	214
Intangible Assets	38	68	84
Noncurrent Deferred & Refundable Income Taxes	20	18	16
Other Noncurrent Operating Assets	77	108	99
Total Liabilities & Shareholders' Equity	1,779	2,068	1,937
Total Liabilities	855	1,163	1,131
Total Current Liabilities	669	787	814
Short-Term Debt	7.86	6.92	12
Accounts Payable	588	691	714
Current Deferred & Payable Income Tax Liabilities	7.90	9.88	0.03
Other Current Liabilities	66	79	88
Total Noncurrent Liabilities	185	376	317
Long-Term Debt	136	323	260
Other Noncurrent Operating Liabilities	49	49	54
Commitments & Contingencies	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	924	905	807
Total Preferred & Common Equity	924	905	807
Preferred Stock	0.00	0.00	0.00
Total Common Equity	924	905	807
Common Stock	26	58	64
Retained Earnings	1,014	937	847
Accumulated Other Comprehensive Income / (Loss)	-116	-90	-105

This table presents ScanSource's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2025	Q2 2025	Q1 2025	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023
Period end date	3/31/2025	12/31/2024	9/30/2024	3/31/2024	12/31/2023	9/30/2023	3/31/2023	12/31/2022	9/30/2022
Total Assets	1,725	1,703	1,787	1,783	1,781	1,899	1,980	2,131	2,000
Total Current Assets	1,310	1,284	1,352	1,416	1,405	1,507	1,578	1,719	1,588
Cash & Equivalents	146	111	145	159	45	43	37	66	40
Accounts Receivable	563	549	567	590	663	692	684	780	745
Inventories, net	476	492	504	529	575	656	753	762	676
Prepaid Expenses	125	132	136	138	122	117	103	111	126
Plant, Property, & Equipment, net	30	30	33	36	0.00	0.00	36	0.00	0.00
Total Noncurrent Assets	385	389	401	331	376	391	366	411	413
Goodwill	229	228	233	208	208	215	215	214	212
Intangible Assets	68	73	78	42	45	64	72	76	79
Noncurrent Deferred & Refundable Income Taxes	18	18	17	19	19	16	14	15	13
Other Noncurrent Operating Assets	70	70	73	63	103	96	65	106	109
Total Liabilities & Shareholders' Equity	1,725	1,703	1,787	1,783	1,781	1,899	1,980	2,131	2,000
Total Liabilities	823	802	866	839	827	983	1,101	1,268	1,173
Total Current Liabilities	632	610	666	643	611	701	744	837	794
Short-Term Debt	9.60	9.90	12	7.86	7.86	8.21	5.98	5.04	4.10
Accounts Payable	541	520	579	556	541	618	657	749	711
Current Deferred & Payable Income Tax Liabilities	13	8.33	6.38	4.79	3.65	8.11	4.44	6.05	5.27
Other Current Liabilities	68	71	69	75	58	67	77	77	74
Total Noncurrent Liabilities	192	192	200	196	217	282	357	431	379
Long-Term Debt	130	132	134	138	161	240	305	378	322
Other Noncurrent Operating Liabilities	61	60	66	58	56	39	49	51	54
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	902	901	921	944	954	915	879	862	827
Total Preferred & Common Equity	902	901	921	944	954	915	879	862	827
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	902	901	921	944	954	915	879	862	827
Common Stock	0.00	0.00	2.98	46	64	60	60	68	66
Retained Earnings	1,023	1,032	1,031	998	985	952	918	897	871
Accumulated Other Comprehensive Income / (Loss)	-122	-131	-113	-100	-95	-96	-99	-103	-110

This table displays calculated financial ratios and metrics derived from ScanSource's official financial filings.

Metric	2024	2023	2022
Period end date	6/30/2024	6/30/2023	6/30/2022
Growth Metrics	-	-	-
Revenue Growth	-13.94%	7.30%	12.03%
EBITDA Growth	-19.29%	8.14%	58.58%
EBIT Growth	-22.90%	11.10%	96.87%
NOPAT Growth	-29.04%	7.54%	88.33%
Net Income Growth	-14.20%	1.14%	722.58%
EPS Growth	-13.56%	2.61%	721.43%
Operating Cash Flow Growth	1,139.02%	71.24%	-206.50%
Free Cash Flow Firm Growth	731.87%	55.33%	-240.26%
Invested Capital Growth	-26.37%	15.32%	28.10%
Revenue Q/Q Growth	-5.81%	-0.40%	3.20%
EBITDA Q/Q Growth	-4.28%	-0.16%	2.03%
EBIT Q/Q Growth	-4.99%	0.15%	2.89%
NOPAT Q/Q Growth	-6.15%	-1.05%	-0.06%
Net Income Q/Q Growth	-3.40%	-1.25%	-4.07%
EPS Q/Q Growth	-3.16%	-0.56%	-4.43%
Operating Cash Flow Q/Q Growth	23.21%	63.94%	-893.38%
Free Cash Flow Firm Q/Q Growth	30.38%	43.81%	-942.69%
Invested Capital Q/Q Growth	-5.16%	4.03%	10.07%
Profitability Metrics	-	-	-
Gross Margin	12.24%	11.86%	12.08%
EBITDA Margin	4.05%	4.31%	4.28%
Operating Margin	2.77%	3.59%	3.46%
EBIT Margin	3.17%	3.54%	3.42%
Profit (Net Income) Margin	2.36%	2.37%	2.52%
Tax Burden Percent	77.18%	73.70%	74.86%
Interest Burden Percent	96.47%	90.78%	98.19%
Effective Tax Rate	22.82%	27.70%	25.23%
Return on Invested Capital (ROIC)	6.70%	8.78%	9.87%
ROIC Less NNEP Spread (ROIC-NNEP)	12.52%	5.58%	8.24%
Return on Net Nonoperating Assets (RNNOA)	1.73%	1.72%	1.68%
Return on Equity (ROE)	8.42%	10.49%	11.55%
Cash Return on Invested Capital (CROIC)	37.07%	-5.46%	-14.77%
Operating Return on Assets (OROA)	5.38%	6.70%	6.69%
Return on Assets (ROA)	4.01%	4.48%	4.92%
Return on Common Equity (ROCE)	8.42%	10.49%	11.55%
Return on Equity Simple (ROE_SIMPLE)	8.34%	9.92%	11.01%
Net Operating Profit after Tax (NOPAT)	70	98	91
NOPAT Margin	2.14%	2.59%	2.59%
Net Nonoperating Expense Percent (NNEP)	-5.82%	3.20%	1.63%
Cost of Revenue to Revenue	87.76%	88.14%	87.92%
SG&A Expenses to Revenue	8.51%	7.54%	7.80%
R&D to Revenue	0.00%	0.00%	0.00%
Operating Expenses to Revenue	9.47%	8.27%	8.62%
Earnings before Interest and Taxes (EBIT)	103	134	121
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	132	163	151
Valuation Ratios	-	-	-
Price to Book Value (P/BV)	1.18	0.81	0.97
Price to Tangible Book Value (P/TBV)	1.61	1.19	1.55
Price to Revenue (P/Rev)	0.34	0.19	0.22
Price to Earnings (P/E)	14.21	8.20	8.85
Dividend Yield	0.00%	0.00%	0.00%
Earnings Yield	7.04%	12.20%	11.30%
Enterprise Value to Invested Capital (EV/IC)	1.19	0.86	0.98
Enterprise Value to Revenue (EV/Rev)	0.32	0.27	0.29
Enterprise Value to EBITDA (EV/EBITDA)	7.99	6.30	6.74
Enterprise Value to EBIT (EV/EBIT)	10.18	7.67	8.43
Enterprise Value to NOPAT (EV/NOPAT)	15.11	10.48	11.15
Enterprise Value to Operating Cash Flow (EV/OCF)	2.83	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	2.73	0.00	0.00
Leverage & Solvency	-	-	-
Debt to Equity	0.16	0.36	0.34
Long-Term Debt to Equity	0.15	0.36	0.32
Financial Leverage	0.14	0.31	0.20
Leverage Ratio	2.10	2.34	2.35
Compound Leverage Factor	2.03	2.12	2.30
Debt to Total Capital	13.48%	26.71%	25.16%
Short-Term Debt to Total Capital	0.74%	0.56%	1.08%
Long-Term Debt to Total Capital	12.74%	26.15%	24.09%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%
Common Equity to Total Capital	86.52%	73.29%	74.84%
Debt to EBITDA	1.09	2.02	1.79
Net Debt to EBITDA	-0.31	1.80	1.54
Long-Term Debt to EBITDA	1.03	1.98	1.72
Debt to NOPAT	2.07	3.36	2.97
Net Debt to NOPAT	-0.59	2.99	2.55
Long-Term Debt to NOPAT	1.95	3.29	2.84
Altman Z-Score	4.09	3.56	3.50
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-
Current Ratio	2.10	2.11	1.87
Quick Ratio	1.15	1.00	0.94
Cash Flow Metrics	-	-	-
Free Cash Flow to Firm (FCFF)	386	-61	-137
Operating Cash Flow to CapEx	4,344.21%	-358.44%	-1,815.65%
Free Cash Flow to Firm to Interest Expense	29.61	-3.09	-20.96
Operating Cash Flow to Interest Expense	28.52	-1.81	-19.06
Operating Cash Flow Less CapEx to Interest Expense	27.86	-2.31	-20.11
Efficiency Ratios	-	-	-
Asset Turnover	1.69	1.89	1.96
Accounts Receivable Turnover	4.88	5.11	5.44
Inventory Turnover	4.50	4.87	5.72
Fixed Asset Turnover	0.00	0.00	0.00
Accounts Payable Turnover	4.47	4.75	4.60
Days Sales Outstanding (DSO)	74.73	71.44	67.13
Days Inventory Outstanding (DIO)	81.03	75.02	63.80
Days Payable Outstanding (DPO)	81.60	76.82	79.33
Cash Conversion Cycle (CCC)	74.16	69.64	51.60
Capital & Investment Metrics	-	-	-
Invested Capital	883	1,199	1,040
Invested Capital Turnover	3.13	3.38	3.81
Increase / (Decrease) in Invested Capital	-316	159	228
Enterprise Value (EV)	1,053	1,030	1,019
Market Capitalization	1,095	736	786
Book Value per Share	$37.41	$36.36	$31.96
Tangible Book Value per Share	$27.53	$24.90	$20.12
Total Capital	1,068	1,235	1,078
Total Debt	144	330	271
Total Long-Term Debt	136	323	260
Net Debt	-41	294	233
Capital Expenditures (CapEx)	8.56	9.98	6.85
Debt-free, Cash-free Net Working Capital (DFCFNWC)	558	841	683
Debt-free Net Working Capital (DFNWC)	743	877	721
Net Working Capital (NWC)	735	870	710
Net Nonoperating Expense (NNE)	-7.35	8.43	2.55
Net Nonoperating Obligations (NNO)	-41	294	233
Total Depreciation and Amortization (D&A)	28	29	30
Debt-free, Cash-free Net Working Capital to Revenue	17.11%	22.20%	19.35%
Debt-free Net Working Capital to Revenue	22.80%	23.16%	20.43%
Net Working Capital to Revenue	22.56%	22.98%	20.10%
Earnings Adjustments	-	-	-
Adjusted Basic Earnings per Share	$3.10	$3.57	$3.48
Adjusted Weighted Average Basic Shares Outstanding	24.87M	25.14M	25.50M
Adjusted Diluted Earnings per Share	$3.06	$3.54	$3.45
Adjusted Weighted Average Diluted Shares Outstanding	25.22M	25.36M	25.76M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	24.03M	24.84M	25.19M
Normalized Net Operating Profit after Tax (NOPAT)	73	98	91
Normalized NOPAT Margin	2.24%	2.59%	2.59%
Pre Tax Income Margin	3.06%	3.22%	3.36%
Debt Service Ratios	-	-	-
EBIT to Interest Expense	7.94	6.78	18.52
NOPAT to Interest Expense	5.35	4.97	14.00
EBIT Less CapEx to Interest Expense	7.29	6.28	17.47
NOPAT Less CapEx to Interest Expense	4.69	4.46	12.95
Payout Ratios	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%
Augmented Payout Ratio	55.66%	17.43%	20.50%

This table displays calculated financial ratios and metrics derived from ScanSource's official financial filings.

Metric	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-6.34%	-15.52%	-11.49%	-21.23%	-15.01%	-12.50%	-7.15%	-1.57%	4.67%	17.03%	10.06%
EBITDA Growth	27.63%	-44.05%	-2.41%	-17.21%	-41.25%	4.88%	-26.26%	-0.74%	1.55%	21.13%	10.15%
EBIT Growth	34.22%	-54.01%	-4.25%	-20.20%	-48.99%	5.25%	-31.44%	0.74%	2.62%	26.72%	13.56%
NOPAT Growth	28.45%	-27.21%	-32.86%	-21.98%	-48.54%	-21.81%	-25.29%	-4.73%	2.28%	16.92%	14.23%
Net Income Growth	36.12%	-47.89%	9.99%	-14.44%	-39.65%	27.17%	-35.81%	-5.69%	-9.80%	10.67%	8.92%
EPS Growth	48.00%	-45.74%	13.11%	-13.16%	-39.76%	27.72%	-35.11%	-2.56%	-8.79%	12.22%	9.30%
Operating Cash Flow Growth	-58.75%	-109.79%	-52.07%	458.69%	192.04%	335.15%	293.01%	80.60%	84.60%	-45.97%	14.92%
Free Cash Flow Firm Growth	-77.91%	30.56%	1,720.44%	337.89%	227.53%	156.24%	105.86%	32.71%	-127.46%	-56.28%	-173.12%
Invested Capital Growth	-3.83%	-13.48%	-17.78%	-26.37%	-19.23%	-8.61%	0.70%	15.32%	22.02%	26.57%	25.34%
Revenue Q/Q Growth	-5.71%	-3.62%	3.95%	-0.86%	-14.94%	0.97%	-7.48%	6.96%	-12.43%	7.14%	-1.92%
EBITDA Q/Q Growth	13.20%	-9.22%	5.61%	17.59%	-50.37%	58.34%	-10.41%	-16.55%	-11.41%	11.33%	20.60%
EBIT Q/Q Growth	22.30%	-15.28%	4.26%	24.25%	-58.09%	76.38%	-13.10%	-20.58%	-13.53%	14.89%	27.68%
NOPAT Q/Q Growth	0.72%	22.45%	-15.98%	23.96%	-42.92%	12.94%	-2.37%	-18.24%	-13.27%	7.91%	24.50%
Net Income Q/Q Growth	2.22%	0.47%	5.45%	25.69%	-60.87%	112.07%	-17.97%	-11.35%	-17.54%	7.04%	20.53%
EPS Q/Q Growth	5.71%	1.45%	4.55%	32.00%	-61.24%	111.48%	-19.74%	-8.43%	-17.82%	7.45%	20.51%
Operating Cash Flow Q/Q Growth	1,167.58%	-113.80%	-18.10%	-65.82%	153.31%	-32.40%	712.89%	-127.83%	303.96%	44.52%	38.41%
Free Cash Flow Firm Q/Q Growth	-67.89%	-24.12%	-35.98%	41.62%	89.78%	958.05%	108.37%	24.08%	16.31%	-10.25%	3.94%
Invested Capital Q/Q Growth	-3.95%	1.16%	4.37%	-5.16%	-13.59%	-3.88%	-6.53%	4.03%	-2.22%	5.91%	7.05%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	14.22%	13.61%	13.10%	13.04%	12.55%	11.39%	12.15%	11.47%	12.62%	11.41%	12.02%
EBITDA Margin	4.37%	3.64%	3.87%	3.80%	3.21%	5.50%	3.51%	3.62%	4.64%	4.59%	4.41%
Operating Margin	3.17%	2.47%	2.27%	2.93%	2.33%	3.03%	2.75%	2.88%	3.87%	3.90%	3.70%
EBIT Margin	3.29%	2.54%	2.89%	2.88%	2.30%	4.67%	2.67%	2.84%	3.83%	3.88%	3.62%
Profit (Net Income) Margin	2.47%	2.28%	2.19%	2.16%	1.70%	3.70%	1.76%	1.99%	2.40%	2.54%	2.55%
Tax Burden Percent	71.95%	86.52%	73.92%	70.92%	71.33%	81.72%	80.60%	80.18%	70.94%	71.10%	74.47%
Interest Burden Percent	104.33%	103.81%	102.45%	105.58%	103.76%	97.00%	81.80%	87.10%	88.19%	92.27%	94.56%
Effective Tax Rate	28.05%	13.48%	26.08%	29.08%	28.67%	18.28%	19.40%	27.14%	29.06%	28.90%	25.53%
Return on Invested Capital (ROIC)	7.43%	6.42%	5.20%	6.51%	5.52%	7.89%	7.38%	7.10%	9.96%	9.89%	9.95%
ROIC Less NNEP Spread (ROIC-NNEP)	-6.36%	7.83%	9.03%	6.97%	5.75%	12.80%	5.76%	6.70%	8.45%	8.93%	9.04%
Return on Net Nonoperating Assets (RNNOA)	0.07%	0.66%	1.01%	0.96%	0.82%	3.10%	1.62%	2.06%	2.06%	2.62%	2.46%
Return on Equity (ROE)	7.50%	7.08%	6.21%	7.47%	6.35%	11.00%	9.00%	9.16%	12.02%	12.51%	12.41%
Cash Return on Invested Capital (CROIC)	10.54%	20.12%	25.75%	37.07%	28.41%	16.66%	7.49%	-5.46%	-10.36%	-14.10%	-13.04%
Operating Return on Assets (OROA)	5.59%	4.41%	4.95%	4.88%	4.23%	8.57%	5.10%	5.38%	7.62%	7.48%	7.08%
Return on Assets (ROA)	4.19%	3.96%	3.75%	3.66%	3.13%	6.80%	3.36%	3.76%	4.77%	4.91%	4.98%
Return on Common Equity (ROCE)	7.50%	7.08%	6.21%	7.47%	6.35%	11.00%	9.00%	9.16%	12.02%	12.51%	12.41%
Return on Equity Simple (ROE_SIMPLE)	7.49%	6.99%	8.54%	0.00%	8.45%	9.25%	8.87%	0.00%	10.35%	10.81%	10.98%
Net Operating Profit after Tax (NOPAT)	16	16	13	16	13	22	19	20	24	28	26
NOPAT Margin	2.28%	2.13%	1.68%	2.08%	1.66%	2.48%	2.22%	2.10%	2.75%	2.77%	2.75%
Net Nonoperating Expense Percent (NNEP)	13.79%	-1.41%	-3.83%	-0.46%	-0.22%	-4.91%	1.62%	0.41%	1.50%	0.96%	0.91%
Return On Investment Capital (ROIC_SIMPLE)	1.54%	1.53%	-	-	-	1.95%	-	-	-	-	-
Cost of Revenue to Revenue	85.78%	86.39%	86.90%	86.96%	87.45%	88.61%	87.85%	88.53%	87.38%	88.59%	87.98%
SG&A Expenses to Revenue	9.89%	9.89%	9.25%	9.18%	8.85%	7.56%	8.61%	7.85%	7.98%	6.83%	7.59%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	11.05%	11.14%	10.83%	10.11%	10.22%	8.35%	9.41%	8.59%	8.75%	7.51%	8.33%
Earnings before Interest and Taxes (EBIT)	23	19	22	21	17	41	23	27	34	39	34
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	31	27	30	28	24	49	31	34	41	46	42
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.88	0.00	1.25	1.18	1.17	1.04	0.82	0.81	0.88	0.86	0.80
Price to Tangible Book Value (P/TBV)	1.32	0.00	1.89	1.61	1.60	1.41	1.18	1.19	1.30	1.29	1.24
Price to Revenue (P/Rev)	0.27	0.00	0.37	0.34	0.32	0.28	0.20	0.19	0.20	0.20	0.18
Price to Earnings (P/E)	11.81	0.00	14.68	14.21	13.90	11.21	9.27	8.20	8.48	7.91	7.33
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	8.47%	0.00%	6.81%	7.04%	7.20%	8.92%	10.78%	12.20%	11.79%	12.64%	13.65%
Enterprise Value to Invested Capital (EV/IC)	0.88	0.00	1.25	1.19	1.18	1.03	0.86	0.86	0.91	0.89	0.85
Enterprise Value to Revenue (EV/Rev)	0.27	0.00	0.37	0.32	0.32	0.31	0.26	0.27	0.27	0.28	0.26
Enterprise Value to EBITDA (EV/EBITDA)	6.80	0.00	8.80	7.99	7.95	7.19	6.29	6.30	6.39	6.46	6.14
Enterprise Value to EBIT (EV/EBIT)	9.19	0.00	11.27	10.18	10.06	8.86	7.76	7.67	7.80	7.92	7.62
Enterprise Value to NOPAT (EV/NOPAT)	13.07	0.00	18.16	15.11	14.75	12.88	10.48	10.48	10.53	10.68	10.06
Enterprise Value to Operating Cash Flow (EV/OCF)	4.96	0.00	3.58	2.83	3.63	5.67	9.02	0.00	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	8.23	0.00	4.39	2.73	3.70	5.92	11.45	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.16	0.16	0.16	0.16	0.15	0.18	0.27	0.36	0.35	0.44	0.39
Long-Term Debt to Equity	0.14	0.15	0.15	0.15	0.15	0.17	0.26	0.36	0.35	0.44	0.39
Financial Leverage	-0.01	0.08	0.11	0.14	0.14	0.24	0.28	0.31	0.24	0.29	0.27
Leverage Ratio	1.90	1.88	2.01	2.10	2.06	2.15	2.24	2.34	2.27	2.39	2.35
Compound Leverage Factor	1.98	1.95	2.06	2.22	2.14	2.09	1.83	2.04	2.00	2.21	2.22
Debt to Total Capital	13.42%	13.61%	13.65%	13.48%	13.38%	15.03%	21.33%	26.71%	26.14%	30.74%	28.30%
Short-Term Debt to Total Capital	0.92%	0.95%	1.09%	0.74%	0.72%	0.70%	0.71%	0.56%	0.50%	0.40%	0.36%
Long-Term Debt to Total Capital	12.50%	12.66%	12.56%	12.74%	12.66%	14.33%	20.62%	26.15%	25.64%	30.34%	27.95%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	86.58%	86.39%	86.35%	86.52%	86.62%	84.97%	78.67%	73.29%	73.86%	69.26%	71.70%
Debt to EBITDA	1.20	1.29	1.11	1.09	1.06	1.09	1.63	2.02	1.90	2.35	2.11
Net Debt to EBITDA	-0.06	0.29	0.00	-0.31	-0.10	0.80	1.35	1.80	1.67	1.94	1.85
Long-Term Debt to EBITDA	1.12	1.20	1.02	1.03	1.00	1.04	1.57	1.98	1.86	2.32	2.08
Debt to NOPAT	2.31	2.49	2.29	2.07	1.96	1.95	2.71	3.36	3.13	3.88	3.45
Net Debt to NOPAT	-0.11	0.55	0.01	-0.59	-0.18	1.43	2.25	2.99	2.76	3.21	3.02
Long-Term Debt to NOPAT	2.15	2.32	2.11	1.95	1.86	1.86	2.62	3.29	3.07	3.83	3.41
Altman Z-Score	3.65	0.00	3.88	3.93	4.07	4.12	3.67	3.39	3.55	3.26	3.29
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.07	2.11	2.03	2.10	2.20	2.30	2.15	2.11	2.12	2.05	2.00
Quick Ratio	1.12	1.08	1.07	1.15	1.16	1.16	1.05	1.00	0.97	1.01	0.99
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	52	161	212	332	234	123	12	-139	-184	-219	-199
Operating Cash Flow to CapEx	4,648.98%	-313.63%	1,887.58%	4,310.16%	6,617.81%	2,479.37%	4,040.30%	-444.93%	2,397.81%	-751.45%	-7,084.65%
Free Cash Flow to Firm to Interest Expense	28.18	81.79	100.68	159.00	117.04	36.74	2.09	-25.06	-32.13	-43.37	-57.72
Operating Cash Flow to Interest Expense	35.98	-3.14	21.26	26.24	80.04	18.82	16.75	-2.74	9.60	-5.31	-14.05
Operating Cash Flow Less CapEx to Interest Expense	35.21	-4.14	20.13	25.63	78.83	18.06	16.33	-3.36	9.20	-6.02	-14.25
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.70	1.74	1.71	1.69	1.84	1.84	1.91	1.89	1.99	1.93	1.96
Accounts Receivable Turnover	5.16	4.99	5.02	4.88	5.43	4.98	5.18	5.11	5.73	5.40	5.42
Inventory Turnover	5.12	4.92	4.77	4.50	4.76	4.74	4.92	4.87	4.99	5.01	5.44
Fixed Asset Turnover	90.68	0.00	0.00	0.00	96.03	0.00	0.00	0.00	0.00	0.00	0.00
Accounts Payable Turnover	4.69	4.95	4.62	4.47	5.03	4.91	4.93	4.75	4.92	4.73	4.84
Days Sales Outstanding (DSO)	70.73	73.19	72.72	74.73	67.20	73.25	70.48	71.44	63.68	67.54	67.35
Days Inventory Outstanding (DIO)	71.30	74.14	76.58	81.03	76.69	77.07	74.16	75.02	73.19	72.86	67.16
Days Payable Outstanding (DPO)	77.77	73.72	78.96	81.60	72.54	74.32	73.97	76.82	74.22	77.12	75.42
Cash Conversion Cycle (CCC)	64.27	73.61	70.34	74.16	71.36	76.00	70.67	69.64	62.65	63.28	59.09
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	895	932	921	883	931	1,077	1,121	1,199	1,153	1,179	1,113
Invested Capital Turnover	3.26	3.01	3.09	3.13	3.32	3.19	3.33	3.38	3.63	3.57	3.61
Increase / (Decrease) in Invested Capital	-36	-145	-199	-316	-222	-101	7.75	159	208	247	225
Enterprise Value (EV)	791	0.00	1,155	1,053	1,095	1,113	958	1,030	1,045	1,054	951
Market Capitalization	798	0.00	1,154	1,095	1,109	989	753	736	772	738	665
Book Value per Share	$38.43	$37.83	$38.32	$37.41	$37.51	$38.19	$36.84	$36.36	$34.67	$34.16	$32.83
Tangible Book Value per Share	$25.79	$25.21	$25.39	$27.53	$27.61	$28.04	$25.62	$24.90	$23.33	$22.66	$21.30
Total Capital	1,042	1,043	1,066	1,068	1,090	1,122	1,163	1,235	1,190	1,245	1,153
Total Debt	140	142	146	144	146	169	248	330	311	383	326
Total Long-Term Debt	130	132	134	136	138	161	240	323	305	378	322
Net Debt	-6.53	31	0.52	-41	-13	124	205	294	274	316	286
Capital Expenditures (CapEx)	1.42	1.97	2.38	1.27	2.42	2.55	2.32	3.43	2.29	3.58	0.68
Debt-free, Cash-free Net Working Capital (DFCFNWC)	542	574	553	558	622	757	772	841	802	821	757
Debt-free Net Working Capital (DFNWC)	688	684	698	743	781	802	815	877	839	887	798
Net Working Capital (NWC)	678	674	686	735	773	795	806	870	833	882	794
Net Nonoperating Expense (NNE)	-1.36	-1.10	-3.94	-0.58	-0.29	-11	3.98	1.07	3.10	2.30	1.94
Net Nonoperating Obligations (NNO)	-6.53	31	0.52	-41	-13	124	205	294	274	316	286
Total Depreciation and Amortization (D&A)	7.59	8.23	7.57	6.89	6.84	7.36	7.31	7.35	7.17	7.15	7.52
Debt-free, Cash-free Net Working Capital to Revenue	18.22%	18.98%	17.50%	17.11%	17.97%	21.08%	20.75%	22.20%	21.09%	21.81%	20.94%
Debt-free Net Working Capital to Revenue	23.13%	22.64%	22.10%	22.80%	22.57%	22.33%	21.90%	23.16%	22.07%	23.58%	22.06%
Net Working Capital to Revenue	22.81%	22.31%	21.73%	22.56%	22.34%	22.11%	21.68%	22.98%	21.91%	23.45%	21.95%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.75	$0.72	$0.70	$0.66	$0.51	$1.31	$0.62	$0.76	$0.84	$1.02	$0.95
Adjusted Weighted Average Basic Shares Outstanding	23.28M	23.81M	24.15M	24.87M	25.03M	25.04M	24.89M	25.14M	25.20M	25.29M	25.20M
Adjusted Diluted Earnings per Share	$0.74	$0.70	$0.69	$0.66	$0.50	$1.29	$0.61	$0.76	$0.83	$1.01	$0.94
Adjusted Weighted Average Diluted Shares Outstanding	23.60M	24.22M	24.65M	25.22M	25.44M	25.33M	25.18M	25.36M	25.44M	25.50M	25.45M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	22.60M	23.46M	0.00	24.03M	24.71M	25.17M	24.97M	24.84M	24.90M	25.35M	25.25M
Normalized Net Operating Profit after Tax (NOPAT)	17	17	17	16	15	22	19	20	24	28	26
Normalized NOPAT Margin	2.37%	2.30%	2.16%	2.08%	2.03%	2.48%	2.22%	2.10%	2.75%	2.77%	2.75%
Pre Tax Income Margin	3.44%	2.64%	2.96%	3.04%	2.39%	4.53%	2.19%	2.48%	3.38%	3.58%	3.42%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	12.65	9.64	10.63	10.31	8.65	12.29	4.19	4.84	5.93	7.75	9.90
NOPAT to Interest Expense	8.75	8.10	6.18	7.44	6.25	6.53	3.48	3.57	4.26	5.54	7.54
EBIT Less CapEx to Interest Expense	11.87	8.64	9.50	9.70	7.44	11.53	3.78	4.23	5.53	7.04	9.70
NOPAT Less CapEx to Interest Expense	7.98	7.10	5.05	6.83	5.04	5.77	3.06	2.96	3.86	4.83	7.34
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	152.45%	149.35%	90.36%	55.66%	32.72%	19.17%	0.00%	17.43%	22.42%	19.32%	0.00%

Frequently Asked Questions About ScanSource's Financials

When does ScanSource's financial year end?

According to the most recent income statement we have on file, ScanSource's fiscal year ends in June. Their fiscal year 2024 ended on June 30, 2024.

How has ScanSource's net income changed over the last 2 years?

ScanSource's net income appears to be on a downward trend, with a most recent value of $77.06 million in 2024, falling from $88.80 million in 2022. The previous period was $89.81 million in 2023. See ScanSource's forecast for analyst expectations on what’s next for the company.

What is ScanSource's operating income?

ScanSource's total operating income in 2024 was $90.32 million, based on the following breakdown:

Total Gross Profit: $399.05 million
Total Operating Expenses: $308.73 million

How has ScanSource revenue changed over the last 2 years?

Over the last 2 years, ScanSource's total revenue changed from $3.53 billion in 2022 to $3.26 billion in 2024, a change of -7.7%.

How much debt does ScanSource have?

ScanSource's total liabilities were at $854.78 million at the end of 2024, a 26.5% decrease from 2023, and a 24.4% decrease since 2022.

How much cash does ScanSource have?

In the past 2 years, ScanSource's cash and equivalents has ranged from $36.18 million in 2023 to $185.46 million in 2024, and is currently $185.46 million as of their latest financial filing in 2024.

How has ScanSource's book value per share changed over the last 2 years?

Over the last 2 years, ScanSource's book value per share changed from 31.96 in 2022 to 37.41 in 2024, a change of 17.0%.

Related Companies

This page (NASDAQ:SCSC) was last updated on 5/21/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

ScanSource (SCSC) Financials

Frequently Asked Questions About ScanSource's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

ScanSource (SCSC) Financials

Annual Income Statements for ScanSource

Quarterly Income Statements for ScanSource

Annual Cash Flow Statements for ScanSource

Quarterly Cash Flow Statements for ScanSource

Annual Balance Sheets for ScanSource

Quarterly Balance Sheets for ScanSource

Annual Metrics And Ratios for ScanSource

Quarterly Metrics And Ratios for ScanSource

Frequently Asked Questions About ScanSource's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools